{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:35:45Z","timestamp":1770435345510,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009797","name":"Barrow Neurological Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["2008620028"],"award-info":[{"award-number":["2008620028"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.expneurol.2009.09.022","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T05:40:47Z","timestamp":1255066847000},"page":"366-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["T-bet deficiency decreases susceptibility to experimental myasthenia gravis"],"prefix":"10.1016","volume":"220","author":[{"given":"Ruolan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos S.","family":"Dayao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise I.","family":"Campagnolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2009.09.022_bib1","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.180.4.2132","article-title":"Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis","volume":"180","author":"Aricha","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.04.018","article-title":"Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+CD25+ regulatory cells","volume":"177","author":"Aruna","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib3","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/eji.200737973","article-title":"CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity","volume":"38","author":"Bai","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2009.09.022_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice","volume":"186","author":"Balasa","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2009.09.022_bib6","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.4049\/jimmunol.161.6.2856","article-title":"The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis","volume":"161","author":"Balasa","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.20031819","article-title":"Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis","volume":"200","author":"Bettelli","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2009.09.022_bib8","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2009.09.022_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clim.1999.4807","article-title":"Animal models of myasthenia gravis","volume":"94","author":"Christadoss","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib10","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2009.09.022_bib11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production","volume":"169","author":"Deng","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib12","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.4049\/jimmunol.175.11.7135","article-title":"CD4+CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells","volume":"175","author":"DiPaolo","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1309\/AQQ2DVM75DVY0PWP","article-title":"T-bet, a T-cell-associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders","volume":"122","author":"Dorfman","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib14","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2009.09.022_bib15","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","article-title":"Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7","volume":"172","author":"Fantini","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2005.02220.x","article-title":"Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment","volume":"116","author":"Fattorossi","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.expneurol.2009.09.022_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni1179","article-title":"A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/intimm\/dxg093","article-title":"T-bet regulates T-independent IgG2a class switching","volume":"15","author":"Gerth","year":"2003","journal-title":"Int. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1490","article-title":"Recent developments in the transcriptional regulation of cytolytic effector cells","volume":"4","author":"Glimcher","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib20","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4049\/jimmunol.178.3.1341","article-title":"T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity","volume":"178","author":"Gocke","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1084\/jem.181.2.547","article-title":"Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction","volume":"181","author":"Gu","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2009.09.022_bib22","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.4049\/jimmunol.174.11.6781","article-title":"Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor","volume":"174","author":"Harris","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1084\/jem.20031873","article-title":"T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes","volume":"199","author":"Juedes","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2009.09.022_bib24","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.4049\/jimmunol.164.10.5236","article-title":"Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL\/6 mice","volume":"164","author":"Karachunski","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-5728(98)00262-8","article-title":"Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor","volume":"95","author":"Karachunski","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0165-5728(95)00169-7","article-title":"Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis","volume":"64","author":"Li","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni941","article-title":"CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells","volume":"4","author":"Liu","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib28","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.175.12.7898","article-title":"Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia","volume":"175","author":"Liu","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib29","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2006-04-015016","article-title":"T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype","volume":"108","author":"Mathur","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2009.09.022_bib30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1196\/annals.1254.032","article-title":"T cells and cytokines in the pathogenesis of acquired myasthenia gravis","volume":"998","author":"Milani","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2009.09.022_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2006.07.004","article-title":"CD4+ T and B cells cooperate in the immunoregulation of experimental autoimmune myasthenia gravis","volume":"179","author":"Milani","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib33","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2487::AID-IMMU2487>3.0.CO;2-Y","article-title":"IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease","volume":"28","author":"Moiola","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib34","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.4049\/jimmunol.166.8.4853","article-title":"Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis","volume":"166","author":"Ostlie","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib35","first-page":"87","article-title":"The T-box transcription factor T-bet in immunity and autoimmunity","volume":"3","author":"Peng","year":"2006","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib36","first-page":"1041","article-title":"The role of T-bet in B cells","author":"Peng","year":"2003","journal-title":"Nat. Immunol. 4, 1041; author reply"},{"key":"10.1016\/j.expneurol.2009.09.022_bib37","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1073\/pnas.082114899","article-title":"T-bet regulates IgG class switching and pathogenic autoantibody production","volume":"99","author":"Peng","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2009.09.022_bib38","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.20052222","article-title":"T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17","volume":"203","author":"Rangachari","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2009.09.022_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.expneurol.2009.09.022_bib40","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.4049\/jimmunol.162.12.7189","article-title":"Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats","volume":"162","author":"Saoudi","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2009.09.022_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1126\/science.1065543","article-title":"Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells","volume":"295","author":"Szabo","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2009.09.022_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaut.2005.01.013","article-title":"Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment","volume":"24","author":"Tuzun","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.expneurol.2009.09.022_bib44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.20052165","article-title":"T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription","volume":"203","author":"Usui","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2009.09.022_bib45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib46","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2009.09.022_bib47","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI26631","article-title":"Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells","volume":"116","author":"Wang","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2009.09.022_bib48","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","article-title":"C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells","volume":"178","author":"Wang","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2009.09.022_bib49","series-title":"Current Protocols in Immunology","article-title":"Experimental autoimmune myasthenia gravis in the mouse","author":"Wu","year":"2008"},{"key":"10.1016\/j.expneurol.2009.09.022_bib50","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.20082584","article-title":"T-bet is essential for encephalitogenicity of both Th1 and Th17 cells","volume":"206","author":"Yang","year":"2009","journal-title":"J. Exp. Med."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488609004099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488609004099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:41:31Z","timestamp":1758001291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488609004099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0014488609004099"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2009.09.022","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-bet deficiency decreases susceptibility to experimental myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2009.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}